Showing 1 posts of 1 posts found.
Dominic Blakemore will join Shire’s Board from January next year as a non-executive director and member of its Audit, Compliance …
Long-acting therapies set to reshape HIV treatment market
MHRA authorises Lynkuet for hot flushes linked to breast cancer therapy
MHRA approves Romvimza for tenosynovial giant cell tumour
NICE recommends allergy immunotherapy tablets for younger children
Dunbar Pharmaceuticals and IPS Pharma announce distribution agreement